Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The antidiuretic effect of arginine vasopressin (AVP) is mediated by renal-type (V2) receptors linked to adenylyl cyclase. We report here the cloning of the rat kidney V2 AVP receptor complementary DNA that encodes a 370-amino-acid protein with a transmembrane topography characteristic of G protein-coupled receptors, and with similarity to the V1a (hepatic) AVP receptor in its seven membrane-spanning domains. Expression of the cloned cDNA in mammalian cells showed specific ligand binding and activity characteristic of the native V2 AVP receptor. The receptor messenger RNA is detected only in the kidney. The human V2 receptor gene has been localized to the long arm of the X chromosome close to the locus for nephrogenic diabetes insipidus, an X-linked recessive disorder characterized by renal resistance to the antidiuretic action of AVP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Frohman, M. A., Dush, M. K., & Martin, G. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8998 · Cited by 4,577
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,293
Cloning and expression of a cDNA encoding an endothelin receptor
Arai, H., Hori, S., Aramori, I., Ohkubo, H., & Nakanishi, S. (1990) · Nature · doi:10.1038/348730a0 · Cited by 2,578
A G Protein-Linked Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide
Jüppner, H., Abou-Samra, A.-B., Freeman, M., Kong, X. F., Schipani, E., Richards, J., Kolakowski, L. F., Hock, J., Potts, J. T., Kronenberg, H. M., et al. (1991) · Science · doi:10.1126/science.1658941 · Cited by 1,249
Yamada, Y., Post, S. R., Wang, K., Tager, H. S., Bell, G. I., & Seino, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.251 · Cited by 753
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Molecular cloning and expression of a rat Via arginine vasopressin receptor
Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J. (1992) · Nature · doi:10.1038/356523a0 · Cited by 477
Self-citationExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451
Research works printed but not linked: 1
- Holmes, M. C., Antoni, F. A. & Szentendrei, T. Neuroendocrinology 117, 421–423 (1985).
Cited by
Nielsen, S., Chou, C. L., Marples, D., Christensen, E. I., Kishore, B. K., & Knepper, M. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1013 · Cited by 1,043
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Simonneaux, V., & Ribelayga, C. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.2 · Cited by 740
“The V2-R is present in the kidney and its coding gene has been cloned in rat (Lolait et al., 1992) and humans (Barberis et al., 1993).”
BackgroundUsdin, T. B., Mezey, E., Button, D. C., Brownstein, M. J., & Bonner, T. I. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243312 · Cited by 534
Self-citationGα15 and Gα16 Couple a Wide Variety of Receptors to Phospholipase C
Offermanns, S., & Simon, M. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15175 · Cited by 498
Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control
Féraille, E., & Doucet, A. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.345 · Cited by 500
Neuroendocrine Control of Body Fluid Metabolism
ANTUNES-RODRIGUES, J., DE CASTRO, M., ELIAS, L. L. K., VALENÇA, M. M., & McCANN, S. M. (2004) · Physiological Reviews · doi:10.1152/physrev.00017.2003 · Cited by 468
“Three different subtypes of AVP receptors, V1a, V1b, and V2, have been cloned (312, 360, 507).”
BackgroundPhysiological Regulation of G Protein-Linked Signaling
Morris, A. J., & Malbon, C. C. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1373 · Cited by 449
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423
Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
“The V2 receptor is found in the renal distal tubules and collecting ducts, and stimulates water absorption (52, 312).”
BackgroundMolecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor.
Sugimoto, T., Saito, M., Mochizuki, S., Watanabe, Y., Hashimoto, S., & Kawashima, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47129-3 · Cited by 378
Aguilera, G., & Rabadan-Diehl, C. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00196-8 · Cited by 375
Do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Luu-The, V., Tsutsui, K., Tonon, M.-C., Pelletier, G., & Vaudry, H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.006 · Cited by 357
Gene Regulation in the Magnocellular Hypothalamo-Neurohypophysial System
Burbach, J. P. H., Luckman, S. M., Murphy, D., & Gainer, H. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1197 · Cited by 340
Yamamura, Y., Nakamura, S., Itoh, S., Hirano, T., Onogawa, T., Yamashita, T., Yamada, Y., Tsujimae, K., Aoyama, M., Kotosai, K., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37873-5 · Cited by 337
Extrapituitary expression of the rat V1b vasopressin receptor gene.
Lolait, S. J., O'Carroll, A. M., Mahan, L. C., Felder, C. C., Button, D. C., Young, W. S., Mezey, E., & Brownstein, M. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6783 · Cited by 337
Self-citationPathophysiology, diagnosis and management of nephrogenic diabetes insipidus
Bockenhauer, D., & Bichet, D. G. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.89 · Cited by 333
AKI Associated with Cardiac Surgery
Thiele, R. H., Isbell, J. M., & Rosner, M. H. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07830814 · Cited by 308
Plasma Copeptin and the Risk of Diabetes Mellitus
Enhörning, S., Wang, T. J., Nilsson, P. M., Almgren, P., Hedblad, B., Berglund, G., Struck, J., Morgenthaler, N. G., Bergmann, A., Lindholm, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909663 · Cited by 299
Hyponatremia in cirrhosis: From pathogenesis to treatment†
Ginés, P., Berl, T., Bernardi, M., Bichet, D. G., Hamon, G., Jiménez, W., Liard, J.-F., Martin, P.-Y., & Schrier, R. W. (1998) · Hepatology · doi:10.1002/hep.510280337 · Cited by 299
MANNING, M., STOEV, S., CHINI, B., DURROUX, T., MOUILLAC, B., & GUILLON, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00437-8 · Cited by 296
Wong, F., Blei, A. T., Blendis, L. M., & Thuluvath, P. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50021 · Cited by 292
Thibonnier, M., Auzan, C., Madhun, Z., Wilkins, P., Berti-Mattera, L., & Clauser, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41863-1 · Cited by 283
Kaufmann, J. E., Oksche, A., Wollheim, C. B., Günther, G., Rosenthal, W., & Vischer, U. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9516 · Cited by 275
“This vasopressin receptor subtype is expressed in the principal cells of renal collecting ducts and mediates the antidiuretic effect of the hormone (7, 8).”
BackgroundArroyo, V., & Colmenero, J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00007-2 · Cited by 279
“The hydroosmotic effect of ADH is initiated by the binding of the hormone to a V2 receptor on the basolateral membrane of the collecting duct epithelial cells [154].”
BackgroundHernando, F. (2001) · Endocrinology · doi:10.1210/en.142.4.1659 · Cited by 275
Self-citationSerradeil-Le Gal, C., Wagnon, J., Garcia, C., Lacour, C., Guiraudou, P., Christophe, B., Villanova, G., Nisato, D., Maffrand, J. P., & Le Fur, G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116554 · Cited by 270
“Determination of the amino acid sequence of human (4) and rat (5) V2 receptors, rat Via AVP receptors (6), and human oxytocin (OT)' receptors (7) clearly confirms that the receptors for neurohypophysial peptides constitute a subfamily of Gprotein-coupled membrane receptors.”
BackgroundOvert nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel
Matsumura, Y., Uchida, S., Kondo, Y., Miyazaki, H., Ko, S. B. H., Hayama, A., Morimoto, T., Liu, W., Arisawa, M., Sasaki, S., et al. (1999) · Nature Genetics · doi:10.1038/5036 · Cited by 276
“The disorders in this process were previously documented by the finding of loss-of-function mutations in genes encoding the vasopressin V2 receptor and the AQP-2 water channel in patients with nephrogenic diabetes insipidu”
BackgroundThe aquaporin family of water channels in kidney
Nielsen, S., & Agre, P. (1995) · Kidney International · doi:10.1038/ki.1995.389 · Cited by 265
The Binding Site of Neuropeptide Vasopressin V1a Receptor
Mouillac, B., Chini, B., Balestre, M.-N., Elands, J., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Jard, S., & Barberis, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25771 · Cited by 262
Tanoue, A., Ito, S., Honda, K., Oshikawa, S., Kitagawa, Y., Koshimizu, T., Mori, T., & Tsujimoto, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19656 · Cited by 258
Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)
Kaufmann, J. E., & Vischer, U. M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00190.x · Cited by 254
Serradeil-Le Gal, C., Lacour, C., Valette, G., Garcia, G., Foulon, L., Galindo, G., Bankir, L., Pouzet, B., Guillon, G., Barberis, C., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119098 · Cited by 250
Evolution of GnRH: Diving deeper
Roch, G. J., Busby, E. R., & Sherwood, N. M. (2011) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2010.12.014 · Cited by 225
Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct.
Sasaki, S., Fushimi, K., Saito, H., Saito, F., Uchida, S., Ishibashi, K., Kuwahara, M., Ikeuchi, T., Inui, K., & Nakajima, K. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117079 · Cited by 214
Cloning and characterization of the human V3 pituitary vasopressin receptor
de Keyzer, Y., Auzan, C., Lenne, F., Beldjord, C., Thibonnier, M., Bertagna, X., & Clauser, E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01268-7 · Cited by 209
Robben, J. H., Knoers, N. V. A. M., & Deen, P. M. T. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00491.2005 · Cited by 194
“The X-linked and most prominent form of congenital NDI is caused by loss-of-function mutations in the AVPR2 gene, encoding the V2R (19, 85), which is a member of the family of G protein-coupled receptors (GPCR; Fig.”
BackgroundStructure, characterization, and expression of the rat oxytocin receptor gene.
Rozen, F., Russo, C., Banville, D., & Zingg, H. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.1.200 · Cited by 191
Plasma Copeptin, A Unifying Factor behind the Metabolic Syndrome
Enhörning, S., Struck, J., Wirfält, E., Hedblad, B., Morgenthaler, N. G., & Melander, O. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2981 · Cited by 177
van den Ouweland, A. M. W., Dreesen, J. C. F. M., Verdijk, M., Knoers, N. V. A. M., Monnens, L. A. H., Rocchi, M., & van Oost, B. A. (1992) · Nature Genetics · doi:10.1038/ng1092-99 · Cited by 183
Cloning and identification of an oxytocin/vasopressin-like receptor and its ligand from insects
Stafflinger, E., Hansen, K. K., Hauser, F., Schneider, M., Cazzamali, G., Williamson, M., & Grimmelikhuijzen, C. J. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710897105 · Cited by 180
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor
Chini, B., Mouillac, B., Ala, Y., Balestre, M. N., Trumpp‐Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., & Jard, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07211.x · Cited by 179
Pan, Y., Metzenberg, A., Das, S., Jing, B., & Gitschier, J. (1992) · Nature Genetics · doi:10.1038/ng1092-103 · Cited by 183
Nephrogenic Diabetes Insipidus
Bichet, D. G. (2006) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2006.01.006 · Cited by 174
Hayashi, M., Sasaki, S., Tsuganezawa, H., Monkawa, T., Kitajima, W., Konishi, K., Fushimi, K., Marumo, F., & Saruta, T. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117525 · Cited by 174
“Vasopressin VI receptor is mainly present in the vascular beds (18) and regulates the contraction of vascular smooth cells, whereas vasopressin V2 receptor localizes exclusively in the collecting duct systems (19) and plays an important role in the regulation of water reabsorption.”
BackgroundFamilial forms of diabetes insipidus: clinical and molecular characteristics
Babey, M., Kopp, P., & Robertson, G. L. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.100 · Cited by 172
“X-linked nephrogenic diabetes insipidus is caused by mutations in the AVPR2 gene”
BackgroundcAMP motifs regulating transcription in the aquaporin 2 gene
Hozawa, S., Holtzman, E. J., & Ausiello, D. A. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.270.6.c1695 · Cited by 161
Regulation of aquaporin-2 water channel trafficking by vasopressin
Knepper, M. A., & Inoue, T. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80034-8 · Cited by 160
Renal aquaporins and water balance disorders
Kortenoeven, M. L. A., & Fenton, R. A. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.12.002 · Cited by 157
Ostrowski, N. L., Young, W. S., Knepper, M. A., & Lolait, S. J. (1993) · Endocrinology · doi:10.1210/endo.133.4.8404628 · Cited by 154
Self-citationStructure, function, and phylogeny of [Arg8]vasotocinreceptors from teleost fish and toad.
Mahlmann, S., Meyerhof, W., Hausmann, H., Heierhorst, J., Schönrock, C., Zwiers, H., Lederis, K. P., & Richter, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1342 · Cited by 153
X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.
Bichet, D. G., Arthus, M., Lonergan, M., Hendy, G. N., Paradis, A. J., Fujiwara, T., Morgan, K., Gregory, M. C., Rosenthal, W., & Didwania, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116698 · Cited by 147
Vasopressin V2receptor expression along rat, mouse, and human renal epithelia with focus on TAL
Mutig, K., Paliege, A., Kahl, T., Jöns, T., Müller‐Esterl, W., & Bachmann, S. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00196.2007 · Cited by 146
Molecular Pharmacology of Human Vasopressin Receptors
Thibonnier, M., Conarty, D. M., Preston, J. A., Wilkins, P. L., Berti‐Mattera, L. N., & Mattera, R. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_34 · Cited by 144
Expression and Signal Transduction Pathways of Gonadotropin-Releasing Hormone Receptors
Stojilković, S. S., & Catt, K. J. (1995) · Elsevier eBooks · doi:10.1016/b978-0-12-571150-0.50012-3 · Cited by 141
Gattone, V. H., Maser, R. L., Tian, C., Rosenberg, J. M., & Branden, M. G. (1999) · Developmental Genetics · doi:10.1002/(sici)1520-6408(1999)24:3/4<252::aid-dvg8>3.0.co;2-k · Cited by 140
Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation
Volpi, S., Rabadan-Diehl, C., & Aguilera, G. (2004) · Stress · doi:10.1080/10253890410001733535 · Cited by 136
“Molecular cloning and pharmacological tools have identified three major receptor subtypes encoded by different genes; kidney V2 receptors, which are coupled to the G-protein, Gs, and adenylate cyclase; V1a receptors, present in smooth muscle and liver, coupled to phospholipase C (PLC); and the pituitary V1b receptors…”
BackgroundVasopressin and oxytocin receptors
Zingg, H. H. (1996) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(96)80314-4 · Cited by 139
The molecular basis of nephrogenic diabetes insipidus
Oksche, A., & Rosenthal, W. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050224 · Cited by 137
“Shortly after localization of the gene causing X-linked NDI to Xq28 [22] and molecular cloning of the vasopressin V2 receptor gene (Table 1) [2, 23, 24] the identification of a frameshift mutation in the V 2 receptor (∆G804, [25]) gave final proof that V 2 receptor mutations are responsible for X-linked NDI.”
BackgroundLi, J., Burton, K. J., Zhang, C., Hu, S.-B., & Zhou, Q. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90463.2008 · Cited by 146
Terada, Y., Tomita, K., Nonoguchi, H., Yang, T., & Marumo, F. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116838 · Cited by 135
Liu, J., & Wess, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8772 · Cited by 135
“%) of sequence identity (Birnbaumer et al., 1992; Lolait et al., 1992; Morel et al., 1992; Sugimoto et al., 1994; de Keyzer et al., 1994).”
Nonoguchi, H., Owada, A., Kobayashi, N., Takayama, M., Terada, Y., Koike, J., Ujiie, K., Marumo, F., Sakai, T., & Tomita, K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118222 · Cited by 132
Thibonnier, M., Preston, J. A., Dulin, N. O., Wilkins, P. L., Berti‐Mattera, L. N., & Mattera, R. (1997) · Endocrinology · doi:10.1210/endo.138.10.5432 · Cited by 138
Bernard, K. F., Bogliolo, S., & Ehrenfeld, J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706103 · Cited by 121
“The vasopressin V2 receptor stimulates the Gs subunit of the heterotrimeric G-protein leading to an increase in intracellular cAMP (Birnbaumer et al., 1992; Lolait et al., 1992).”
BackgroundRood, B. D., Stott, R. T., You, S., Smith, C. J. W., Woodbury, M. E., & De Vries, G. J. (2013) · Journal of Comparative Neurology · doi:10.1002/cne.23288 · Cited by 120
“…(Yates et al., 1971), and the pathway ending in the posterior pituitary is crucial for peripheral AVP release, which affects distal target organs such as the liver, kidney, heart, and blood vessels (Lolait et al., 1992; Morel et al., 1992; Ostrowski et al., 1992, 1993, 1994; Saito et al., 1995).”
BackgroundChini, B., Mouillac, B., Balestre, M.-N., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Andriolo, M., Pupier, S., Jard, S., & Barberis, C. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01135-0 · Cited by 117
Molecular neurobiology and pharmacology of the Vasopressin/Oxytocin receptor family
Burbach, J. P. H., Burbach, H., Adan, R. A. H., Lolait, S. J., van Leeuwen, F. W., Mezey, É., Palkovits, M., & Barberis, C. (1995) · Cellular and Molecular Neurobiology · doi:10.1007/bf02071318 · Cited by 119
“These are the OT (Kimura et at., 1992), the V~ (Morel et al., 1992; Thibonnier et al., 1994), the V~b (Sugimoto et al., 1994a,b; de Keyzer et al., 1994; Lolait et al., 1995), and the V2 receptors (Birnbaumer et al., 1992; Lolait et al., 1992 ).”
BackgroundMethodInfluentialSelf-citationGeneration and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene
Yun, J. S., Schöneberg, T., Liu, J., Schulz, A. M., ECELBARGER, C. A., Promeneur, D., Nielsen, S., SHENG, H. Z., Grinberg, A., Deng, C., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9154 · Cited by 116
“Sequence analysis (9, 10) indicates that the V2R protein is a typical member of the superfamily of G protein–coupled receptors that are characterized by the presence of seven transmembrane domains.”
BackgroundTolvaptan, an Orally Active Vasopressin V2‐Receptor Antagonist—Pharmacology and Clinical Trials
Miyazaki, T., Fujiki, H., Yamamura, Y., Nakamura, S., & Mori, T. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00001.x · Cited by 125
Alteration of Glucose Homeostasis in V1a Vasopressin Receptor-Deficient Mice
Aoyagi, T., Birumachi, J.-I., Hiroyama, M., Fujiwara, Y., Sanbe, A., Yamauchi, J., & Tanoue, A. (2007) · Endocrinology · doi:10.1210/en.2006-1315 · Cited by 113
Pathophysiological roles of arginine vasopressin and aquaporin‐2 in impaired water excretion
Ishikawa, S., & Schrier, R. W. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01647.x · Cited by 112
“Lolait et al. (1992) and Birnbaumer et al. (1992) independently cloned AVP V2 receptors in rat and human kidneys, respectively.”
BackgroundCo-evolution of Ligand-Receptor Pairs in the Vasopressin/Oxytocin Superfamily of Bioactive Peptides
van Kesteren, R. E., Tensen, C. P., Smit, A. B., van Minnen, J., Kolakowski, L. F., Meyerhof, W., Richter, D., van Heerikhuizen, H., Vreugdenhil, E., & Geraerts, W. P. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3619 · Cited by 125
Thibonnier, M., Berti‐Mattera, L. N., Dulin, N. O., Conarty, D. M., & Mattera, R. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61568-x · Cited by 112
Acher, R. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90174-7 · Cited by 109
Ala, Y., Morin, D., Mouillac, B., Sabatier, N., Vargas‐Poussou, R., de la Cotte, N., Déchaux, M., Antignac, C., Arthus, M., Lonergan, M., et al. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9101861 · Cited by 111
The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
de Keyzer, Y., Lenne, F., Auzan, C., Jégou, S., René, P., Vaudry, H., Kuhn, J., LUTON, J. P., Clauser, É., & BERTAGNA, X. Y. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118547 · Cited by 104
Regulation of Transport in the Connecting Tubule and Cortical Collecting Duct
Staruschenko, A. (2012) · Comprehensive physiology · doi:10.1002/cphy.c110052 · Cited by 128
Hormonal regulation of ion and water transport in anuran amphibians
Uchiyama, M., & Konno, N. (2006) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2005.12.018 · Cited by 105
Nephrogenic diabetes insipidus
Bichet, D. G. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00301-5 · Cited by 105
Overview of cellular electrophysiological actions of vasopressin
Raggenbass, M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.074 · Cited by 117
“Rat and human vasopressin V1A receptors present in liver or blood vessels smooth muscle have been cloned and sequenced (Hirasawa et al., 1994; Morel et al., 1992; Thibonnier et al., 1994), as have been renal vasopressin V2 receptors (Birnbaumer et al., 1992; Lolait et al., 1992).”
BackgroundOxytocin as an antidiuretic hormone. II. Role of V2 vasopressin receptor
Chou, C., DiGiovanni, S. R., Luther, A., Lolait, S. J., & Knepper, M. A. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.269.1.f78 · Cited by 101
Self-citationHurbin, A., Boissin‐Agasse, L., Orcel, H., Rabié, A., Joux, N., Desarménien, M. G., Richard, P., & Moos, F. (1998) · Endocrinology · doi:10.1210/endo.139.11.6320 · Cited by 103
Gorbulev, V., BÜCHNER, H., Akhundova, A., & Fahrenholz, F. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18000.x · Cited by 100
Cellular and subcellular distribution of the type-2 vasopressin receptor in the kidney
Fenton, R. A., Brønd, L., Nielsen, S. M., & Prætorius, J. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00316.2006 · Cited by 99
“The type-2 vasopressin receptor (V2R) (2, 32), a member of the large seven-transmembrane class 1 G protein-coupled receptor family (21), mediates the antidiuretic effects of AVP.”
Silver, P. B., Chan, C., Wiggert, B. O., & Caspi, R. R. (1999) · PubMed · Cited by 99
Marie, J., Maigret, B., Joseph, M.-P., Larguier, R., Nouet, S., Lombard, C., & Bonnafous, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31893-8 · Cited by 99
Effects of central vasopressin administration to infant rats
Winslow, J., & Insel, T. R. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90354-k · Cited by 100
Copeptin is an independent predictor of diabetic heart disease and death
Enhörning, S., Hedblad, B., Nilsson, P. M., Engström, G., & Melander, O. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.11.020 · Cited by 108
Calcitonin Receptor-stimulating Peptide, a New Member of the Calcitonin Gene-related Peptide Family
Katafuchi, T., Kikumoto, K., Hamano, K., Kangawa, K., Matsuo, H., & Minamino, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207970200 · Cited by 95
A methionine-Mettl3-N-methyladenosine axis promotes polycystic kidney disease
Ramalingam, H., Kashyap, S., Cobo-Stark, P., Flaten, A., Chang, C.-M., Hajarnis, S. S., Hein, K. Z., Lika, J., Warner, G. M., Espíndola‐Netto, J. M., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.024 · Cited by 98
Copeptin predicts coronary artery disease cardiovascular and total mortality
Tasevska, I., Enhörning, S., Persson, M., Nilsson, P. M., & Melander, O. (2015) · Heart · doi:10.1136/heartjnl-2015-308183 · Cited by 98
Vasopressin and Oxytocin in Control of the Cardiovascular System
Japundžić‐Žigon, N. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311020008 · Cited by 98
ECELBARGER, C. A., Chou, C., Lolait, S. J., Knepper, M. A., & DiGiovanni, S. R. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.4.f623 · Cited by 89
Self-citationRegulation of Pituitary Vasopressin V1b Receptor mRNA during Stress in the Rat
Rabadan‐Diehl, C., Lolait, S. J., & Aguilera, G. (1995) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1995.tb00734.x · Cited by 86
“oxytocin receptors (22-25), and the maximal number of shared contiguos nucleotides identical with these receptor cDNA is 15”
BackgroundSelf-citationHereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update
Milano, S., Carmosino, M., Gerbino, A., Svelto, M., & Procino, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112385 · Cited by 98
“The antidiuretic action of AVP (Figure 1) begins upon binding to type-2 vasopressin receptor (AVPR2) [6], a G protein-coupled receptor localized at the basolateral plasma membrane of the principal cells of the kidney collecting duct (Figure 1).”
BackgroundMolecular biology of vasopressin receptors
LOLAIT, S. J., O'CARROLL, A., & BROWNSTEIN, M. J. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44688.x · Cited by 87
Self-citationOxytocin and vasopressin in the rodent hippocampus
Cilz, N. I., Cymerblit‐Sabba, A., & Young, W. S. (2018) · Genes Brain & Behavior · doi:10.1111/gbb.12535 · Cited by 99
Molecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla
Grazzini, E., Lodboerer, A. M., Pérez‐Martin, A., BRESSION, D., & Guillon, G. (1996) · Endocrinology · doi:10.1210/endo.137.9.8756565 · Cited by 87
van Kesteren, R. E., Tensen, C. P., Smit, A. B., van Minnen, J., van Soest, P. F., Kits, K. S., Meyerhof, W., Richter, D., van Heerikhuizen, H., Vreugdenhil, E., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90180-9 · Cited by 88
Metadata
- Authors
- Lolait, S. J., O'Carroll, A.-M., McBride, O. W., Konig, M., Morel, A., & Brownstein, M. J.
- Affiliations
- National Institute of Mental Health (US)
- National Institutes of Health (US)
- Venue
- Nature
- Published
- 1992-05
- Volume
- 357
- Issue
- 6376
- Pages
- 336-339
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2131706912
- Cited by
- 524
- References
- 27
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 3 · 2023: 8 · 2022: 5 · 2021: 15 · 2020: 5 · 2019: 10 · 2018: 10 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 10 · 2013: 16 · 2012: 8
- FWCI
- 15.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- Explore Bristol Research (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- V2 receptor, vasopressin, nephrogenic diabetes insipidus, G protein-coupled receptors, adenylate cyclase, antidiuretic effect, kidney, receptor cloning, cDNA expression, X chromosome, X-linked recessive disorder, receptor mRNA expression
- MeSH terms
- Adenylyl Cyclases, Amino Acid Sequence, Animals, Base Sequence, Chromosome Mapping, Cloning, Molecular, Diabetes Insipidus, DNA, Humans, Kidney, Genetic Linkage, Molecular Sequence Data, Receptors, Angiotensin, Translocation, Genetic, X Chromosome, Restriction Mapping, Gene Expression, Polymerase Chain Reaction, Receptors, Vasopressin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.